Johns Hopkins Team Develops Nasal DNA Vaccine as New Therapeutic Approach for Tuberculosis
In a groundbreaking advancement in the fight against one of humanity’s oldest and deadliest foes, researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg...
















